SNIPR also provided a clinical update on its ongoing Phase 1b trial of SNIPR001 in patients with hematological cancer undergoing hematopoietic stem-cell transplantation (HSCT). Recruitment in this ...
Rapid results for ADHD, Anxiety and OCD: Improves executive function and lessens the din of unwelcome thoughts. Calms the overactive amygdala to assist patients in processing trauma free of physical ...
Fagron, the leading global player in pharmaceutical compounding, announces the successful completion of its acquisition of Vepakum in Latin America. The transaction, announced in December 2025, was ...
Peters brings over 15 years of senior care and financial expertise to advance Care@Home 4 Life's mission of keeping seniors safely in the homes they love. Miami, FL, March 02, 2026 (GLOBE NEWSWIRE) -- ...
MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the pricing of its ...
J.P. Morgan is acting as the underwriter for the offering.
Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility own ...
Inducement Plan. Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a ...
Interested parties may access the live webcasts of the fireside chats by visiting the Investors & Media section of the Cytokinetics website at http://www.cytokinetics.com. The webcast replays will be ...
Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received ...
The Raymond James 47 th Annual Institutional Investors Conference will take place at the JW Marriott Grande Lakes, Orlando. About RadNet, Inc. RadNet, Inc. is a leading national provider of ...
An archived replay of the webcast will be available on the Tenaya website for approximately 30 days following the conference. About Tenaya Therapeutics Tenaya Therapeutics is a clinical-stage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results